Matt vs Myeloma

Pages

Home
Resources

Thursday, October 27, 2022

A New Treatment Option for Myeloma Patients

U.S. FDA Approves TECVAYLI™ (teclistamab-cqyv), the First Bispecific T-cell Engager Antibody for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

at October 27, 2022

Email This BlogThis!Share to Twitter Share to Facebook Share to Pinterest

No comments:

I Confess

I confess, I don't write very much anymore. So I'm using this post to spill all the beans, in no particular order. Take a break if y...

My Multiple Myeloma Story

On May 2, 2011 I was diagnosed with Multiple Myeloma. I had never heard of it before but know all about it now. It's a bone marrow and blood cancer. I began chemotherapy on May 3. I created this blog to keep folks up to date with my health, my treatment, and my adventure.

Matt's articles on blood-cancer.com

Blood-cancer.com

Report Abuse

Simple theme. Powered by Blogger.

Pages

Thursday, October 27, 2022

A New Treatment Option for Myeloma Patients

No comments:

Post a Comment

I Confess